EntroGen, a leading manufacturer of cancer diagnostic products, is seeking a highly motivated and experienced individual to fill a research scientist position. The job requires extensive knowledge of molecular biology, particularly with expertise in real-time PCR assay development and optimization. Primary responsibility includes design, development and validation of new products for detection of germline and somatic mutations implicated in the pathogenesis of various cancers.
The ideal candidate will possess knowledge and experience in:
- PCR/qPCR assay development and optimization
- Custom NGS panel development and optimization
- Performing library preparation and running NGS instruments
- Bioinformatics data analysis on NGS data
- advanced molecular biology techniques
- development of new SOP’s
- providing technical guidance to other R&D team members
Experience with scientific writing is required. Ability to handle and prioritize multiple projects simultaneously is required. Knowledge of regulatory compliance and understanding GMP/GLP regulated environment is a plus.
Ph.D. in molecular biology or related discipline. A successful applicant will possess above average verbal and writing skills.
EntroGen provides a nurturing and rewarding small company environment where team work and success go hand in hand. The company culture fosters innovation and staff development while appreciating individual contributors. We offer competitive compensation and benefits.
Job Type: Full-time
- industry: 2 years (Preferred)
- qPCR: 2 years (Required)
- Doctorate (Required)
- United States (Required)
- One location
- Paid time off
- Health insurance
- Parental leave
- Dental insurance
- Gym memberships or discounts
Must be authorized to work in the U.S. No relocation assistance provided. No agencies.
Please send resume and salary history to email@example.com. No agencies, please.
EntroGen is a biotechnology company with a focus on molecular diagnostic products in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time PCR-based tests, with many of its products being used to guide and monitor targeted therapies for various malignancies. EntroGen’s footprint reaches every corner of the globe delivering reliable clinical and research products